Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 8/2009

01-08-2009 | Brief Report

Molecular insights into the phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates: a Bayesian approach

Authors: Sook Hee Yoon, Wooseog Jeong, Hyun-Jeong Kim, Dong-Jun An

Published in: Archives of Virology | Issue 8/2009

Login to get access

Abstract

A Bayesian approach was utilized to further investigate the molecular phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates, and the complete VP2 gene sequences for 23 Korean isolates in 2007 and two vaccine strains were determined. Of the 44 Korean CPVs, 40 were identified as CPV-2a, three as CPV-2b, and the remaining one as a CPV-2a variant having a Gly300Asp mutation. Compared with CPV-2a, our findings also showed the presence of six additional amino acid substitutions (Thr440Ala, Ile418Thr, Pro435Ser, Asp413Asn, Thr322Ser, and Tyr324Ile) within the VP2 gene of the Korean isolates. In the phylogenetic tree, the overall Korean CPVs did not emerge as an independent clade within the global CPVs, nor did they show a close relationship to the CPVs from any other country. Our VP2 sequence data also revealed no geographic influence on the spread of CPVs worldwide. dN/dS analysis showed that purifying selection is acting on the VP2 gene of Korean CPVs.
Literature
1.
Abascal F, Zardoya R, Posada D (2005) Pro test: selection of best-fit models of protein evolution. Bioinformatics 20:2104–2105CrossRef
2.
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723CrossRef
3.
Appel MJG, Scott FW, Carmichael LE (1979) Isolation and immunization studies of a canine parvo-like virus from dogs with haemorrhagic enteritis. Vet Rec 105:156–159PubMed
4.
Buonavoglia C, Martella V, Pratelli A, Tempesta M, Cavalli A, Buonavoglia D, Bozzo G, Elia G, Decaro N, Carmichael L (2001) Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 82:3021–3025PubMed
5.
Chapman MS, Rossmann MG (1993) Structure, sequence, and function correlations among parvoviruses. Virology 194:491–508PubMedCrossRef
6.
Decaro N, Martella V, Desario C, Bellacicco AL, Camero M, Manna L, d’Aloja D, Buonavoglia C (2006) First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J Vet Med 53:468–472CrossRef
7.
Hall TA (1999) BIOEDIT: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
8.
Huelsenbeck JP, Ronquist F (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754–755PubMedCrossRef
9.
Ikeda Y, Mochizuki M, Naito R, Nakamura K, Miyazawa T, Mikami T, Takahashi E (2000) Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology 5:13–19CrossRef
10.
Kang BK, Song DS, Lee CS, Jung KI, Park SJ, Kim EM, Park BK (2008) Prevalence and genetic characterization of canine parvoviruses in Korea. Virus Genes 36:127–133PubMedCrossRef
11.
Kapil S, Cooper E, Lamm C, Murray B, Rezabek G, Johnston L 3rd, Campbell G, Johnson B (2007) Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol 45:4044–4047PubMedCrossRef
12.
Ku JL, Seo IB, Lim CH (1994) Histopathological and immunohistochemical studies on the intestinal lesions related to the infected age in spontaneous canine parvovirus enteritis. Korean J Vet Res 34:537–547
13.
Martella V, Decaro N, Buonavoglia C (2006) Evolution of CPV-2 and implication for antigenic/genetic characterization. Virus Genes 33:11–13PubMedCrossRef
14.
Mochizuki M, Horiuchi M, Hiragi H, San Gabriel MC, Yasuda N, Uno T (1996) Isolation of canine parvovirus from a cat manifesting clinical signs of feline panleukopenia. J Clin Microbiol 34:2101–2105PubMed
15.
Moon HS, Lee SA, Lee SG, Choi R, Jeoung SY, Kim D, Hyun C (2008) Comparison of the pathogenicity in three different Korean canine parvovirus 2 (CPV-2) isolates. Vet Microbiol 131:47–56PubMedCrossRef
16.
Nakamura M, Tohya Y, Miyazawa T, Mochizuki M, Phung HT, Nguyen NH, Huynh LM, Nguyen LT, Nguyen PN, Nguyen PV, Nguyen NP, Akashi H (2004) A novel antigenic variant of Canine parvovirus from a Vietnamese dog. Arch Virol 149:2261–2269PubMedCrossRef
17.
Nielsen R, Yang Z (1998) Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929–936PubMed
18.
Page RDM (1996) TREEVIEW: an application to display phylogenetic trees on a personal computer. Comput Appl Biosci 12:357–358PubMed
19.
Park JH, Song JY, Lee JB, Hyun BH, An SH, Jun MH (1992) Restriction endonuclease analysis of canine parvovirus DNA isolated in Korea. Korean J Vet Res 32:597–603
20.
Parrish CR (1991) Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology 183:195–205PubMedCrossRef
21.
Parrish CR, Aquadro CF, Strassheim ML, Evermann JF, Sgro JY, Mohammed HO (1991) Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol 65:6544–6552PubMed
22.
Pereira CA, Leal ES, Durigon EL (2007) Selective regimen shift and demographic growth increase associated with the emergence of high-fitness variants of canine parvovirus. Infect Genet Evol 7:399–409PubMedCrossRef
23.
Posada D, Crandall KA (1998) Modeltest: testing the model of DNA substitution. Bioinformatics 14:817–818PubMedCrossRef
24.
Qin Q, Loeffler IK, Li M, Tian K, Wei F (2007) Sequence analysis of a canine parvovirus isolated from a red panda (Ailurus fulgens) in China. Virus Genes 34:299–302PubMedCrossRef
25.
Ronquist F, Huelsenbeck JP (2003) MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19:1572–1574PubMedCrossRef
26.
Shackelton LA, Parrish CR, Truyen U, Holmes EC (2005) High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc Natl Acad Sci 102:379–384PubMedCrossRef
27.
Strimmer K, von Haeseler A (1996) Quartet puzzling: a quartet maximum likelihood method for reconstructing tree topologies. Mol Biol Evol 13:964–969
28.
Suyama M, Torrents D, Bork P (2006) PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res: W609–W612. Nucleic Acids Res 34:W609–W612PubMedCrossRef
29.
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The Clustal-windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 22:4673–4680CrossRef
30.
Wang HC, Chen WD, Lin SL, Chan JP, Wong ML (2005) Phylogenetic analysis of canine parvovirus VP2 gene in Taiwan. Virus Genes 31:171–174PubMedCrossRef
31.
Yang Z (1997) PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13:555–556PubMed
32.
Yuan W, Parrish CR (2000) Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Virology 269:471–480PubMedCrossRef
Metadata
Title
Molecular insights into the phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates: a Bayesian approach
Authors
Sook Hee Yoon
Wooseog Jeong
Hyun-Jeong Kim
Dong-Jun An
Publication date
01-08-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0444-3

Other articles of this Issue 8/2009

Archives of Virology 8/2009 Go to the issue

Original Article

Interaction of tomato yellow leaf curl virus with diverse betasatellites enhances symptom severity

Original Article

Characterization of full-length VP4 genes of OP354-like P[8] human rotavirus strains detected in Bangladesh representing a novel P[8] subtype

Original Article

Identification of amino acid residues of Ljungan virus VP0 and VP1 associated with cytolytic replication in cultured cells

Original Article

Sequence and gene organization of 24 circles from the Cotesia plutellae bracovirus genome

Brief Report

Molecular and biological characterization of natural variants of Citrus dwarfing viroid

Original Article

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits